What Is LLY Fair Value?
Eli Lilly and Company (LLY) fair value estimate using multiple valuation models, updated daily.
As of September 15, 2026, Eli Lilly and Company (LLY) has a composite fair value estimate of $1,300.16 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $1,136.11, suggesting the stock is fair value by 14.4%.
Data as of September 15, 2026 (today)
Composite Fair Value
Fair Value4 of 4 models$1,300.16
vs. current price of $1,136.11(+14.4%)
How Is LLY Fair Value Calculated?
Four independent models estimate what LLY is worth. Each uses different inputs and assumptions. The composite blends them by weight.
LLY Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$1,884.08
+65.8%Undervalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$735.33
-35.3%Overvalued
Inputs used
LLY Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$177.21
-84.4%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$1,479.04
+30.2%Undervalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $1136.11 is 65.8% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $19.35B | $18.07B |
| Year 2 | $24.19B | $21.09B |
| Year 3 | $30.23B | $24.62B |
| Year 4 | $37.79B | $28.73B |
| Year 5 | $47.24B | $33.54B |
| Year 6 | $59.05B | $39.15B |
| Year 7 | $73.81B | $45.70B |
| Year 8 | $92.27B | $53.34B |
| Year 9 | $115.33B | $62.26B |
| Year 10 | $144.17B | $72.67B |
| Terminal Value | $3.22T | $1.62T |
What Are LLY's Key Financial Metrics?
Earnings & Growth
Current Price
$1,136.11
EPS (TTM)
$29.82
Forward P/E
24.0
Profit Margin
33.5%
Cash & Balance Sheet
Free Cash Flow
11.1B
EBITDA
41.7B
Book Value
$38.00
Total Debt
54.9B
What Do Analysts Say About LLY?
Low
$930.00
Average
$1,324.87
High
$1,600.00
Upside
+16.6%
LLY Fair Value FAQ
What is the fair value of LLY?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), LLY's estimated fair value is $1,300.16. The stock is currently trading at $1,136.11, which makes it fair value by our analysis.
How is LLY's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is LLY overvalued or undervalued?
Based on our analysis, LLY is fair value. The current price of $1,136.11 is 14.4% below our estimated fair value of $1,300.16.
What do Wall Street analysts say about LLY?
29 analysts cover Eli Lilly and Company with a consensus rating of "Buy." The average price target is $1,324.87, ranging from $930.00 to $1,600.00. This implies 16.6% upside from the current price.